glp-1 injection side effects GLP-1RA Essentials in Gastroenterology: Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment Understanding GLP-1 side effects

While patient preference is clearly shifting toward non-injectable options, injectables are projected to retain a 75% market share by 2035, not the minority

A recent multicenter international phase II RCT (GOLDEN-505) in noncirrhotic biopsy-proven NASH patients showed an insignificant difference in NASH resolution without fibrosis progression between the elafibranor and placebo groups at 52 weeks of treatment

Statistical methods Demographic and anthropomorphic variables were characterized with means and standard deviations for continuous variables and counts and percentages for categorical variables

doi: 10.1038/s41575-020-0316-6

Heres what you can do to stay safe: 1

Clin Med Rev Case Rep